New concept in natural history and management of diabetes mellitus in thalassemia major diabetes and thalassaemia

Hemoglobin

Volumn 33, Issue SUPPL. 1, 2009, Pages

  Chatterjee, Ratna ^a   Bajoria, Rekha ^a,b  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Diabetes mellitus; Fructosamine; HbA1C; Pancreatic T2; Thalassemia

Indexed keywords

ACARBOSE; DEFERIPRONE; DEFEROXAMINE;

CHELATION; CONFERENCE PAPER; CONTINUOUS INFUSION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; HUMAN; HYPERINSULINISM; IMPAIRED GLUCOSE TOLERANCE; IRON CHELATION; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; THALASSEMIA MAJOR; URINE VOLUME;

BETA-THALASSEMIA; DIABETES MELLITUS; DISEASE MANAGEMENT; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING;

EID: 73949118610     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/09553000903347880     Document Type: Conference Paper

References (10)

1. Diabetes mellitus in thalasseamia-TIF guidelines, 2008.
2. Au WY, Lam WW, Chu W, et al. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major. Haematologica. 2008;93:116-119.
3. Lassman MN, Genel M, Wise JK, et al.Carbohydrate homeostasis and pancreatic islet cell function in thalassemia. Ann Intern Med. 1974;80:65-69.
4. Bunn HF, Forget BG, Ranney HM. Hemoglobinopathies (review). Major Probl Intern Med. 1977;12:1-291.
5. Costin G, Kogut MD, Hyman C, et al. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major. Diabetes. 1977;26:230-240.
6. Mowla A, Karimi M, Afrasiabi A, et al. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection. Pediatr Endocrinol Rev. 2004;2(Suppl. 2):282-284.
7. British National Formulatory, 58th ed. London: BMJ Group and RPS Publishing. 2000. www.bnf.org
8. Messina MF, Lombardo F, Meo A, et al. Three-year prospective evaluation of glucose tolerance, beta-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major. J Endocrinol Invest. 2002;25:497-501.
9. Platis O, Anagnostopoulos G, Farmaki K, et al. Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy. Pediatr Endocrinol Rev. 2004;2(Suppl. 2):279-281.
10. Christoforidis A, Perifanis V, Athanassiou-Metaxa M. Combined chelation therapy improves glucose metabolism in patients with beta-thalassaemia major. Br J Haematol. 2006;135(2):271-272.